Therapeutic Advances in Gastroenterology Q1 Unclaimed
Therapeutic Advances in Gastroenterology is a journal indexed in SJR in Gastroenterology with an H index of 66. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on gastroenterology, gastrointestinal disorders, hepatic disorders, hepatology. It has an SJR impact factor of 1,189 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,189.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1800 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,189
SJR Impact factor66
H Index145
Total Docs (Last Year)385
Total Docs (3 years)8306
Total Refs1606
Total Cites (3 years)374
Citable Docs (3 years)3.89
Cites/Doc (2 years)57.28
Ref/DocOther journals with similar parameters
Nature Reviews Gastroenterology and Hepatology Q1
Lancet Gastroenterology and Hepatology, The Q1
The Lancet Gastroenterology and Hepatology Q1
Gut Q1
Gastroenterology Q1
Compare this journals
Aims and Scope
Best articles by citations
Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B
View moreScreening for celiac disease in average-risk and high-risk populations
View moreManagement of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis
View morePrevalence of colonic adenomas in patients with nonalcoholic fatty liver disease
View morePeroxisome proliferator-activated receptors and hepatitis C virus
View moreSalvage therapy using self-expandable metal stents for recalcitrant anastomotic strictures after living-donor liver transplantation
View moreRifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence
View moreNoncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
View moreStructured management strategy versus usual care for gastroesophageal reflux disease: rationale for pooled analysis of five European cluster-randomized trials
View moreThe role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency
View moreCurrent and future role of magnetically assisted gastric capsule endoscopy in the upper gastrointestinal tract
View moreAre we making progress in preventing Barrett's-related esophageal cancer?
View moreHow should we classify and treat patients with functional gastrointestinal disorders?
View moreAn 'omental patch' created during over-the-scope clipping completely sealed a duodenal perforation after endoultrasonography
View moreExperience with biosimilar infliximab (CT-P13) in paediatric patients with inflammatory bowel diseases
View moreCorrelation between serum gastrin and cellular proliferation in Barrett's esophagus
View moreRecent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology
View moreReview: Improving compliance with Helicobacter pylori eradication therapy: when and how?
View moreReview: Advances in the diagnosis and treatment of small bowel lesions with Crohn's disease using double-balloon endoscopy
View moreSafety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients
View moreThe mucosal microbiota in a young child with severe non-Helicobacter gastritis
View morePersistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease
View moreReview: Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?
View moreEfficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection
View more
Comments